Andrew Sinclair Insider Profile

11 Followers
Andrew Sinclair, Director at Soleno Therapeutics, holds 6.50K shares in Soleno Therapeutics (Ticker: SLNO), holds 11.80K shares in Adicet Bio (Ticker: ACET), holds 0.00 shares in Sierra Oncology (Ticker: SRRA).
tipranks
Andrew Sinclair

Andrew Sinclair
Soleno Therapeutics (SLNO)
Director

Ranked #27,047 out of 99,335 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+11.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$400K
96.28%
3.72%
0.00%
A breakdown of Andrew Sinclair's holdings

Insider Roles

Soleno Therapeutics
(SLNO)
Director
Adicet Bio
(ACET)
Director
Verona Pharma
(VRNA)
Director
Roles that Andrew Sinclair holds in companies

Most Profitable Insider Trade

Stock:
Soleno Therapeutics
(SLNO)
Rating:Informative Buy
Date:Dec 27, 2018 - Dec 27, 2019
Return:+64.40%
The most profitable trade made by Andrew Sinclair

Andrew Sinclair's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Soleno Therapeutics
Jun 10, 2024
Director
Uninformative Buy
$384.67K
SRRA
Sierra Oncology
Jul 01, 2022
Uninformative Sell
72.28M
$0.00
Adicet Bio
Jun 07, 2024
Director
Uninformative Buy
$14.87K
Verona Pharma
Director
List of latest transactions for each holding click on a transaction to see Andrew Sinclair's performance on stock

Andrew Sinclair insider profile FAQ

What is the percentage of profitable transactions made by Andrew Sinclair?
The percentage of profitable transactions made by Andrew Sinclair is 75%.
    What is the average return per transaction made by Andrew Sinclair?
    The average return per transaction made by Andrew Sinclair is 11.10%.
      What stocks does Andrew Sinclair hold?
      Andrew Sinclair holds: SLNO, SRRA, ACET, VRNA stocks.
        What was Andrew Sinclair’s latest transaction?
        Andrew Sinclair latest transaction was an Uninformative Buy of ―.
          What was Andrew Sinclair's most profitable transaction?
          Andrew Sinclair’s most profitable transaction was an Informative Buy of SLNO stock on December 27, 2018. The return on the trade was 64.40%.
            What is Andrew Sinclair's role in Soleno Therapeutics?
            Andrew Sinclair's role in Soleno Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.